[TENAGA] QoQ Cumulative Quarter Result on 30-Sep-2024 [#3]

Announcement Date
28-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 73.35%
YoY- 71.24%
Quarter Report
View:
Show?
Cumulative Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 42,358,800 28,007,200 13,640,400 53,066,900 39,414,900 25,948,800 12,625,600 123.61%
PBT 4,672,100 2,796,700 1,029,800 3,373,600 2,699,700 1,644,200 1,102,700 161.15%
Tax -850,300 -606,400 -351,900 -770,000 -620,500 -442,400 -171,800 189.57%
NP 3,821,800 2,190,300 677,900 2,603,600 2,079,200 1,201,800 930,900 155.73%
-
NP to SH 3,744,100 2,159,800 715,700 2,770,300 2,186,400 1,330,200 1,002,300 140.17%
-
Tax Rate 18.20% 21.68% 34.17% 22.82% 22.98% 26.91% 15.58% -
Total Cost 38,537,000 25,816,900 12,962,500 50,463,300 37,335,700 24,747,000 11,694,700 120.96%
-
Net Worth 59,119,109 59,068,049 57,946,818 58,668,477 57,761,953 57,994,981 57,847,770 1.45%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 1,448,955 1,446,937 - 2,655,047 1,037,992 1,036,097 - -
Div Payout % 38.70% 66.99% - 95.84% 47.47% 77.89% - -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 59,119,109 59,068,049 57,946,818 58,668,477 57,761,953 57,994,981 57,847,770 1.45%
NOSH 5,795,820 5,812,780 5,787,331 5,787,331 5,787,331 5,787,331 5,753,077 0.49%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 9.02% 7.82% 4.97% 4.91% 5.28% 4.63% 7.37% -
ROE 6.33% 3.66% 1.24% 4.72% 3.79% 2.29% 1.73% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 730.85 483.90 235.69 919.41 683.50 450.81 219.46 122.51%
EPS 64.60 37.32 12.37 48.00 37.91 23.11 17.42 139.01%
DPS 25.00 25.00 0.00 46.00 18.00 18.00 0.00 -
NAPS 10.2003 10.2057 10.0127 10.1646 10.0166 10.0754 10.0551 0.95%
Adjusted Per Share Value based on latest NOSH - 5,796,926
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 730.71 483.14 235.30 915.43 679.93 447.63 217.80 123.61%
EPS 64.59 37.26 12.35 47.79 37.72 22.95 17.29 140.18%
DPS 25.00 24.96 0.00 45.80 17.91 17.87 0.00 -
NAPS 10.1984 10.1895 9.9961 10.1206 9.9642 10.0044 9.979 1.45%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 14.44 13.78 11.38 10.04 9.99 9.05 9.23 -
P/RPS 1.98 2.85 4.83 1.09 1.46 2.01 4.21 -39.44%
P/EPS 22.35 36.93 92.02 20.92 26.35 39.16 52.98 -43.66%
EY 4.47 2.71 1.09 4.78 3.80 2.55 1.89 77.23%
DY 1.73 1.81 0.00 4.58 1.80 1.99 0.00 -
P/NAPS 1.42 1.35 1.14 0.99 1.00 0.90 0.92 33.45%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 28/11/24 29/08/24 31/05/24 27/02/24 24/11/23 25/08/23 29/05/23 -
Price 13.98 13.94 13.04 11.42 10.00 9.97 9.75 -
P/RPS 1.91 2.88 5.53 1.24 1.46 2.21 4.44 -42.92%
P/EPS 21.64 37.36 105.44 23.79 26.37 43.14 55.96 -46.82%
EY 4.62 2.68 0.95 4.20 3.79 2.32 1.79 87.83%
DY 1.79 1.79 0.00 4.03 1.80 1.81 0.00 -
P/NAPS 1.37 1.37 1.30 1.12 1.00 0.99 0.97 25.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment